Advanced Therapies Journal

Advanced Therapies Journal

Advanced Therapies Journal

Journal Archive

Advanced Therapies Journal was first published in 2018 as pharmacogenomics and Omics technologies  Journal and in 2023 reviewed for optimization and reformed to advanced therapies journal. Now ATJ is a premium home for the publication of interdisciplinary research on the next-generation of therapeutics and advanced therapies. The articles selected for the Editors' Choice are representative of the key topics that the journal publishes, including targeted drug delivery; drug discovery; cellular, genetic, and immunotherapies; personalized and precision medicines; theranostics; omics technologies, tissue engineering, pharmacology; toxicology, and highlight work done by researchers from across the globe.

Most Visited Articles
Advantages, Disadvantages and Risks of CRISPR/cas9 Technique for Gene Therapy
A Review of Medicinal Plant Extracts for the Treatment of Antibiotic-Resistant Wounds
Synthetic Biology in Genomics: Redefining Genetic Engineering and Its Applications in Personalized Medicine
Advancements and Potential Future Applications of Medication Delivery Systems Using Nanotechnology
Personalized Medicine Approach in the Treatment and Status of Autoimmune Diseases
CD40-CD40L Co-Stimulatory Pathway: A Promising Immune-Therapeutic Target in Systemic Lupus Erythematosus
Metabolic Syndrome and Inflammatory Diseases: A Comprehensive Review of Mechanisms and Management
Current Issue: Volume 8, Issue 26, Winter 2026, Pages 1-53 

Publication Information

Publisher
AmitisGen TECH Dev Group
Editor-in-Chief
Dr. Sina Salari
Director-in-Charge
Dr. Mohammad Ali Saremi
Executive Manager
Nayyere Moslehi
Frequency
Quarterly
Print ISSN
3115-7394
Online ISSN
3060-6152

Indexing and Abstracting

Google Scholar
Magiran
Civilica

Keywords Cloud

  • Personalized Medicine
  • Artificial intelligence
  • Machine Learning
  • Immunotherapy
  • precision medicine
  • Genomic analysis
  • Systemic lupus erythematosus
  • Biomarkers
  • Autoimmune disorders
  • breast cancer
  • Multi-omics integration
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
  • Genomics
  • Gene Therapy
  • probiotics
  • Drug resistance
  • Rheumatoid arthritis
  • Pharmacogenomics
  • CAR-T cell therapy toxicities
  • COVID-19
  • systemic lupus erythematosus (SLE)
  • Cytokine Release Syndrome (CRS)
  • cancer vaccine
  • Nanoparticles
  • Gut microbiota
  • Cancer treatment
  • Cancer therapy
  • Multiple Sclerosis
  • Synthetic biology
  • Advanced Therapies
  • cancer
  • nanomedicine
  • Acute pain
  • Metabolic Syndrome
  • Drug targeting
  • medicinal plants
  • Aromatase Inhibitors (AIs)
  • immune modulation
  • Tumor Microenvironment
  • Antibiotic resistance pediatric populations
  • phage display
  • individualized therapy
  • Vaccine development
  • Cancer Genomics
  • Cytokines
  • pharmacokinetics
  • Controlled drug delivery
  • tyrosine kinase inhibitors
  • Personalized therapies
  • Severity of disease
  • Metastasis
  • solid tumors
  • Antimicrobial
  • Monoclonal antibodies
  • Live materials
  • Genetic engineering
  • Lactococcus lactis
  • wound dressing
  • mRNA Vaccines
  • NSCLC
  • Hydrogel
  • viral vector vaccines
  • Light-activated therapy
  • hydrogels
  • Cyclin-Dependent Kinase Inhibitors (CDK)
  • cancer immunotherapy
  • Traditional vaccines
  • Adoptive-cell therapy
  • Drug Development
  • Sickle cell disease
  • burn management
  • Biomaterials
  • COVID-19 meta-analysis
  • Phenylalanine ammonia-lyase
  • Health behavior
  • Age-Related Diseases
  • PD-1
  • Autoimmune Diseases
  • breast malignancies
  • Air pollution
  • immune system
  • CD40-CD40L pathway
  • geriatric healthcare
  • Oncolytic Viruses
  • Precision Diagnostics
  • colorectal cancer
  • lupus nephritis
  • Tumor lysis
  • Neurofilament Light Chain
  • risk factors
  • RET fusion
  • Pharmacological therapy
  • Urinary exosomes
  • Particulate Matter
  • Personalized therapy
  • Bacteriophage
  • Cellular Functions
  • Next-Generation Sequencing (NGS)
  • Precision Neurology
  • reactive oxygen species
  • CD154/CD40
  • Cancer management
  • Natural Antimicrobials
  • KRAS signaling
  • RET alterations
  • Personalized medicine. Neutrophil
  • Inflammation
  • PBSC Manifestation
  • Lung cancer
  • cell therapy
  • Chimeric antigen receptor
  • Chronic wounds
  • Solid Tumor
  • metabolomic signatures, Targeted therapy, Omics technologies
  • Antibiotic Resistance
  • Biomarker-guided
  • age
  • Psoriasis
  • Vaccinia virus
  • Diabetic foot ulcers
  • Regenerative medicine
  • DNA vaccine
  • therapy
  • infection prevention
  • Selective Estrogen Receptors Modulator (SERM)
  • Nanotechnology
  • Photodynamic therapy
  • targeted cancer therapy
  • Genomic data
  • Diabetes Mellitus
  • live biotherapeutic products
  • Precision oncology
  • Antimicrobial Resistance
  • tumor vaccine
  • Alzheimer’s disease
  • targeted therapy
  • Multidisciplinary pain management
  • Nanocarriers
  • Drug Delivery
  • Phenylketonuria
  • Radiation therapy
  • smoking
  • Tissue engineering
  • psoriatic arthritis
  • personalized treatments
  • Elderly Care
  • gout
  • cytokine
  • Prostate Cancer
  • Non-pharmacological therapy
  • CRISPR/Cas9
  • Personalized Healthcare
  • CTLA-4
  • PD-L1
  • Drug delivery system
  • Autoimmune Disease
  • bioactive scaffolds
  • TKI
  • Viral Vector
  • plasmid engineering
  • Immune checkpoint inhibitors
  • β-thalassemia
  • Brachytherapy
  • Synthetic vaccines
  • non-invasive
  • neuroinflammation
  • Chronic pain
  • Cancer progression
  • Comprehensive analysis
  • Antibiotic delivery
  • Resistance Patterns
  • Body\'s response
  • immunological systems